Investseekers cites IQVIA data showing Lilly still leading the US obesity market while Novo's Wegovy line declined.
Recap by typeshit. Post by Investseekers on X.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
A personal diary entry built around a protein shake and a fresh mindset. It's light on detail and reads mostly as motivation.
One product appeared to come from a 'research use only' vendor called AlphaLabs. Harvard's Pieter Cohen urges the FDA to investigate; Public Citizen counts at least 14 hospitalizations.
Loading…